Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 1Venous Thromboembolism 1

Interventions

Dalteparin 12apixaban 9Enoxaparin 8Tinzaparin 6edoxaban 5Rivaroxaban 5Heparin, Low-Molecular-Weight 4Fondaparinux 3Dabigatran 3bemiparin 2abelacimab 2Warfarin 2Nadroparin 2MAA868 2Heparin 2reviparin 1myotubularin 1isoquercitrin 1certoparin 1calcium heparin 1atezolizumab 1acarboxyprothrombin 1Ultrasonography, Doppler, Duplex 1Rosuvastatin Calcium 1Phenprocoumon 1Models, Biological 1Medication Therapy Management 1Laparoscopy 1Intermittent Pneumatic Compression Devices 1Imaging, Three-Dimensional 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Venous Thrombosis × calcium heparin × Clear all
NCT01444612 2017-05-16

Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery

GlaxoSmithKline

Completed
4,068 enrolled
Classical hematology

Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡